Stock Analiz

Agios Pharmaceuticals, Inc. (AGIO) stock forecast and price target

Price $31.59 · data as of November 13, 2026

12-month price target

Average target$46.11
Upside / downside+46.0%
Analysts9
ConsensusBuy
Low $32.00Average $46.11High $74.00

Gold marker: average target · white marker: today’s price ($31.59)

Analyst ratings

Strong buy 0Buy 7Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-5.56+21.9%$186M
Next fiscal year
ends December 31, 2027
$-3.11+42.5%$345M
Next quarter
ends December 31, 2026
$-1.09+41.0%$65M
Quarter after
ends March 31, 2027
$-0.81+52.1%$71M

Consensus of the analysts covering Agios Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Agios Pharmaceuticals stock price target?

The average 12-month target from 9 analysts is $46.11, 46.0% above the current price of $31.59 Targets range from $32.00 to $74.00.

Is Agios Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (7 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Agios Pharmaceuticals expected to earn?

Analysts expect EPS of $-5.56 for the fiscal year ending December 31, 2026 and $-3.11 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.